Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-08-14
2007-08-14
Angell, Jon (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
10135629
ABSTRACT:
The invention relates to the use of alpha 1-antichymotrypsin (ACT) polypeptides according to SEQ ID No. 1 to SEQ ID No. 4 and/or nucleic acids encoding them, or an antibody or a fragment thereof directed against the polypeptide, or of a cell which is expressing the polypeptide or a nucleic acid encoding it, for diagnosis, treatment and/or prevention of diabetes-associated and/or arterial wounds which heal poorly and for identifying pharmacologically active substances which exert an influence on the expression or function, particularly the activity of ACT.
REFERENCES:
patent: 5367064 (1994-11-01), Rubin et al.
patent: 0 162 812 (1985-11-01), None
patent: 0 432 117 (1991-06-01), None
patent: 1 114 862 (2001-07-01), None
patent: WO95/27053 (1995-10-01), None
patent: WO95/27055 (1995-10-01), None
Witkowski et al. Biochemistry (1999) vol. 38, pp. 11643-11650.
Seffernick et al. Journal of Bacteriology (2001) vol. 183(8), pp. 2405-2410.
Chandra et al., “Sequence Homology Between Human α1-Antichymotrypsin, α1-Antitrypsin, and Antithrombin III,”Biochemistry22:5055:5060 (1983).
Dobschuetz et al., “Inhibition of Neutrophil Proteinases by Recombinant Serpin Lex032 Reduces Capillary No-Reflow in Ischemia/Reperfusion-Induced Acute Pancreatitis,”The Journal of Pharmacology and Experimental Therapeutics290:782-788 (1999).
Eriksson et al., “Familial α1-Antichymotrypsin Deficiency,”Acta Med Scand220:447-453 (1986).
Glinski et al., “Decreased Specific Anti-Elastase Activity in the Uninvolved Skin of Patients with Psoriasis,”Arch Dermatol Res283:224-229 (1991).
Harvima et al., “Decreased Chymase Activity is Associated with Increased Levels of Protease Inhibitors in Mast Cells of Psoriatic Lesions,”Acta Derm Venereol79:98-104 (1999).
Inglis et al., “Isolation of Two cDNAs Encoding Novel α1-Antichymotrypsin-Like Proteins in a Murine Chondrocytic Cell Line,”Gene106:213-220 (1991).
Kalsheker et al., “α1-Antichymotrypsin”Int. J. Biochem. Cell Biol. 28:961-964 (1996).
Kelly et al., “The Assessment of Antichymotrypsin in Cancer Monitoring,”Biomedicine28:209-215 (1978).
Lindmark et al., “Heterozygous α1-Antichymotrypsin Deficiency May be Associated with Cold Urticaria,”Allergy47:456-458 (1992).
Morii et al., “Amino Acid Sequence at the Reactive Site of Human α1-Antichymotrypsin,”The Journal of Biological Chemistry258:12749-12752 (1988).
Rubin et al., “Conversion of α1-Antichymotrypsin Into a Human Neutrophil Elastase Inhibitor: Demonstration of Variants with Different Association Rate Constants, Stoichiometries of Inhibition, and Complex Stabilities,”Biochemistry33:7627-7633 (1994).
Schick et al., “Squamous Cell Carcinoma Antigen 2 is a Novel Serpin that Inhibits the Chymotrypsin-Like Proteinases Cathepsin G and Mast Cell Chymase,”The Journal of Biological Chemistry272:1849-1855 (1997).
Tegner et al., “Quantitation of Human Granulocyte Protease Inhibitors in Non-Purulent Bronchial Lavage Fluids,”Acta Otolaryngol85:282-289 (1978).
Travis et al., “Human α-1-Antichymotrypsin: Interaction with Chymotrypsin-Like Proteinases,”Biochemistry17:5651-5656 (1978).
Goppelt Andreas
Halle Jörn-Peter
Hof Peter
Angell Jon
Clark & Elbing LLP
Switch Biotech AG
LandOfFree
Use of α 1-antichymotrypsin polypeptides, or nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of α 1-antichymotrypsin polypeptides, or nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of α 1-antichymotrypsin polypeptides, or nucleic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850474